Michael Ory
Family Medicine · Vacherie, LANPI 1962410597
Payments from drug & device makers
Across 82 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$252
- AbbVie$148
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$118
- Bayer$117
- Sanofi-aventis U.S. LLC$108
- Boehringer Ingelheim$107
- plus $473 from 14 others
What the payments were for
- Food & beverage$1,323100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $252 |
| AbbVie(2 entities) | 9 | $148 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $118 |
| Bayer | 7 | $117 |
| Sanofi-aventis U.S. LLC | 8 | $108 |
| Boehringer Ingelheim | 7 | $107 |
| Amgen | 5 | $92 |
| GSK | 3 | $54 |
| Pfizer | 3 | $49 |
| AstraZeneca | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Merck | 2 | $32 |
| Exact Sciences | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Almatica Pharma LLC | 1 | $28 |
| Boston Scientific | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
| Johnson & Johnson | 1 | $11 |
How this compares
$1,323 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 41 | $30,812 |
| TradjentaLinagliptin | 27 | $19,982 |
| JardianceEmpagliflozin | 13 | $13,600 |
| FarxigaDapagliflozin Propanediol | 21 | $12,277 |
| JentaduetoLinagliptin/Metformin Hcl | 11 | $11,612 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $10,413 |
| LinzessLinaclotide | 15 | $8,164 |
| XareltoRivaroxaban | 12 | $6,695 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,178 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,099 |
| Levothyroxine Sodium | 157 | $1,069 |
| Nebivolol Hcl | 28 | $1,050 |
| Amlodipine Besylate | 304 | $1,016 |
| Betamethasone Valerate | 32 | $974 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 15 | $888 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance, Jentadueto | $107 | $45,19551 claims |
| MerckJanuvia | $32 | $30,81241 claims |
| AstraZenecaFarxiga | $47 | $12,27721 claims |
| GSKTrelegy Ellipta | $54 | $10,41312 claims |
| AbbVieLinzess | $148 | $8,16415 claims |
| Johnson & JohnsonXarelto | $11 | $6,69512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Vacherie
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
- Kristen ThomasNew Orleans$361K
- Clint WilsonBossier City$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.